Showing results (1501-1510 of 1,753) with videos related to

Sort By:
Pageof 176
Scientific Reports|June 9, 2021
Gene expression changes and DNA damage after ex vivo exposure of peripheral blood cells to various CT photon spectraHanns Leonhard Kaatsch, Benjamin Valentin Becker, Simone Schüle, et al.
Digital Health|November 4, 2024
Web-based telemedicine approach for treatment of post-COVID-19 in Thuringia (WATCH)Philipp A Reuken, Bianca Besteher, Jutta Bleidorn, et al.
Intensive & Critical Care Nursing|January 31, 2026
Feasibility of implementing a multi-component intervention of environmental control in mechanically ventilated ICU patients to improve sleep: A pilot randomized controlled trialVanessa Oviedo, Leyla Alegría, Douglas Leonard, et al.
Neurology and Therapy|May 27, 2026
Inter-assay and Inter-site Performance of Alpha-Synuclein Seed Amplification Assays in Synucleinopathies: A Multicenter 2 × 2 Protocol ComparisonRoger Plaza-Clar, Maximilian Weber, Vaibhavi Kadam, et al.
Plos One|September 23, 2015
Age and Vascular Burden Determinants of Cortical Hemodynamics Underlying Verbal FluencySebastian Heinzel, Florian G Metzger, Ann-Christine Ehlis, et al.
Bulletin of the Menninger Clinic|January 6, 2011
Patterns of interpersonal problems and their improvement in depressive and anxious patients treated with psychoanalytic therapySimone Salzer, Eric Leibing, Thorsten Jakobsen, et al.
NPJ Parkinson'S Disease|October 25, 2024
CSF d18:1 sphingolipid species in Parkinson disease and dementia with Lewy bodies with and without GBA1 variantsStefanie Lerche, Isabel Wurster, Enza Maria Valente, et al.
Journal of Parkinson'S Disease|February 20, 2025
Predictive potential of circular walking in prodromal Parkinson's diseaseM Encarna Micó-Amigo, Idsart Kingma, Sebastian Heinzel, et al.
NPJ Parkinson'S Disease|January 19, 2024
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson's diseaseKathrin Brockmann, Stefanie Lerche, Simone Baiardi, et al.
Biological Psychiatry|November 17, 2009
Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depressionBettina H Bewernick, René Hurlemann, Andreas Matusch, et al.
Pageof 176